{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:13:18Z","timestamp":1779909198232,"version":"3.53.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T00:00:00Z","timestamp":1585526400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T00:00:00Z","timestamp":1585526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Application Research of Capital Clinical Characteristics","award":["Z181100001718082"],"award-info":[{"award-number":["Z181100001718082"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81301119"],"award-info":[{"award-number":["81301119"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Beijing Municipal Administration of Hospitals\u2019 Youth Programme","award":["QML20160504"],"award-info":[{"award-number":["QML20160504"]}]},{"name":"the China Association Against Epilepsy-UCB Research Fund","award":["CAAE- UCB2016008"],"award-info":[{"award-number":["CAAE- UCB2016008"]}]},{"name":"the Natural Science Foundation of Capital Medical University","award":["PYZ2017055"],"award-info":[{"award-number":["PYZ2017055"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurosci"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Patients positive for anti-glutamic acid decarboxylase 65 (GAD65) antibodies have attracted increasing attention. Their clinical manifestations are highly heterogeneous and can be comorbid with tumors. Currently, there is no consensus on the therapeutic regimen for anti-GAD65-associated neurological diseases due to the clinical complexity, rarity and sporadic distribution. We reported six anti-GAD65 autoimmune encephalitis (AE) patients who received intravenous methylprednisolone (IVMP) or immunoglobulin (IVIG) or both. Then, we evaluated the therapeutic effect of both by summarizing results in previous anti-GAD65 AE patients from 70 published references.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our six patients all achieved clinical improvements in the short term. Unfortunately, there was no significant difference between IVMP and IVIG in terms of therapeutic response according to the previous references, and the effectiveness of IVMP and IVIG was 45.56% and 36.71%, respectively. We further divided the patients into different subgroups according to their prominent clinical manifestations. The response rates of IVMP and IVIG were 42.65% and 32.69%, respectively, in epilepsy patients; 60.00% and 77.78%, respectively, in patients with stiff-person syndrome; and 28.57% and 55.56%, respectively, in cerebellar ataxia patients. Among 29 anti-GAD65 AE patients with tumors, the response rates of IVMP and IVIG were 29.41% and 42.11%, respectively. There was no significant difference in effectiveness between the two regimens among the different subgroups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Except for stiff-person syndrome, we found that this kind of AE generally has a poor response to IVMP or IVIG. Larger prospective studies enrolling large numbers of patients are required to identify the optimal therapeutic strategy in the future.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12868-020-00561-9","type":"journal-article","created":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T14:02:49Z","timestamp":1585576969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Intravenous methylprednisolone or immunoglobulin for anti-glutamic acid decarboxylase 65 antibody autoimmune encephalitis: which is better?"],"prefix":"10.1186","volume":"21","author":[{"given":"Tao-Ran","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Di","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Qiu","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9927-847X","authenticated-orcid":false,"given":"Rui-Juan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,30]]},"reference":[{"key":"561_CR1","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.yebeh.2018.01.021","volume":"80","author":"A Daif","year":"2018","unstructured":"Daif A, Lukas RV, Issa NP, Javed A, VanHaerents S, Reder AT, Tao JX, Warnke P, Rose S, Towle VL, et al. Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy. Epilepsy Behav. 2018;80:331\u20136.","journal-title":"Epilepsy Behav"},{"issue":"1","key":"561_CR2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/ana.25131","volume":"83","author":"D Dubey","year":"2018","unstructured":"Dubey D, Pittock SJ, Kelly CR, McKeon A, Lopez-Chiriboga AS, Lennon VA, Gadoth A, Smith CY, Bryant SC, Klein CJ, et al. Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol. 2018;83(1):166\u201377.","journal-title":"Ann Neurol"},{"key":"561_CR3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3389\/fncel.2016.00130","volume":"10","author":"JK Hackert","year":"2016","unstructured":"Hackert JK, M\u00fcller L, Rohde M, Bien CG, K\u00f6hling R, Kirschstein T. Anti-GAD65 containing cerebrospinal fluid does not alter GABAergic transmission. Front Cell Neurosci. 2016;10:130.","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"561_CR4","doi-asserted-by":"publisher","first-page":"e0121364","DOI":"10.1371\/journal.pone.0121364","volume":"10","author":"N Gresa-Arribas","year":"2015","unstructured":"Gresa-Arribas N, Ari\u00f1o H, Mart\u00ednez-Hern\u00e1ndez E, Petit-Pedrol M, Sabater L, Saiz A, Dalmau J, Graus F. Antibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunity. PLoS ONE. 2015;10(3):e0121364.","journal-title":"PLoS ONE"},{"issue":"1","key":"561_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/mus.25565","volume":"56","author":"A McKeon","year":"2017","unstructured":"McKeon A, Tracy JA. GAD65 neurological autoimmunity. Muscle Nerve. 2017;56(1):15\u201327.","journal-title":"Muscle Nerve"},{"issue":"11","key":"561_CR6","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1001\/jamaneurol.2015.2378","volume":"72","author":"AL Jones","year":"2015","unstructured":"Jones AL, Flanagan EP, Pittock SJ, Mandrekar JN, Eggers SD, Ahlskog JE, McKeon A. Responses to and outcomes of treatment of autoimmune cerebellar ataxia in adults. JAMA Neurol. 2015;72(11):1304\u201312.","journal-title":"JAMA Neurol"},{"issue":"8","key":"561_CR7","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1001\/jamaneurol.2015.0749","volume":"72","author":"H Ari\u00f1o","year":"2015","unstructured":"Ari\u00f1o H, H\u00f6ftberger R, Gresa-Arribas N, Mart\u00ednez-Hern\u00e1ndez E, Armangue T, Kruer MC, Arpa J, Domingo J, Rojc B, Bataller L, et al. Paraneoplastic neurological syndromes and glutamic acid decarboxylase antibodies. JAMA Neurol. 2015;72(8):874\u201381.","journal-title":"JAMA Neurol"},{"issue":"4","key":"561_CR8","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1017\/cjn.2016.13","volume":"43","author":"MM Gagnon","year":"2016","unstructured":"Gagnon MM, Savard M. Limbic encephalitis associated with GAD65 antibodies: brief review of the relevant literature. Can J Neurol Sci. 2016;43(4):486\u201393.","journal-title":"Can J Neurol Sci"},{"issue":"9","key":"561_CR9","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.4065\/81.9.1207","volume":"81","author":"SJ Pittock","year":"2006","unstructured":"Pittock SJ, Yoshikawa H, Ahlskog JE, Tisch SH, Benarroch EE, Kryzer TJ, Lennon VA. Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. Mayo Clin Proc. 2006;81(9):1207\u201314.","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"561_CR10","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1001\/archneurol.2011.177","volume":"68","author":"CM Korff","year":"2011","unstructured":"Korff CM, Parvex P, Cimasoni L, Wilhelm-Bals A, Hampe CS, Schwitzgebel VM, Michel M, Siegrist CA, Lalive PH, Seeck M. Encephalitis associated with glutamic acid decarboxylase autoantibodies in a child: a treatable condition. Arch Neurol. 2011;68(8):1065\u20138.","journal-title":"Arch Neurol"},{"key":"561_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.seizure.2015.05.017","volume":"30","author":"MP Malter","year":"2015","unstructured":"Malter MP, Frisch C, Zeitler H, Surges R, Urbach H, Helmstaedter C, Elger CE, Bien CG. Treatment of immune-mediated temporal lobe epilepsy with GAD antibodies. Seizure. 2015;30:57\u201363.","journal-title":"Seizure"},{"issue":"4","key":"561_CR12","doi-asserted-by":"publisher","first-page":"e353","DOI":"10.1212\/NXI.0000000000000353","volume":"4","author":"AM Feyissa","year":"2017","unstructured":"Feyissa AM, L\u00f3pez Chiriboga AS, Britton JW. Antiepileptic drug therapy in patients with autoimmune epilepsy. Neurol Neuroimmunol Neuroinflamm. 2017;4(4):e353.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"561_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/jca.21342","volume":"30","author":"MS Farooqi","year":"2015","unstructured":"Farooqi MS, Lai Y, Lancaster E, Schmitt SE, Sachais BS. Therapeutic plasma exchange and immunosuppressive therapy in a patient with anti-GAD antibody-related epilepsy: quantification of the antibody response. J Clin Apher. 2015;30(1):8\u201314.","journal-title":"J Clin Apher"},{"issue":"3","key":"561_CR14","doi-asserted-by":"publisher","first-page":"E50","DOI":"10.1542\/peds.109.3.e50","volume":"109","author":"JA Olson","year":"2002","unstructured":"Olson JA, Olson DM, Sandborg C, Alexander S, Buckingham B. Type 1 diabetes mellitus and epilepsia partialis continua in a 6-year-old boy with elevated anti-GAD65 antibodies. Pediatrics. 2002;109(3):E50.","journal-title":"Pediatrics"},{"issue":"1","key":"561_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000050758","volume":"46","author":"M Sinnreich","year":"2001","unstructured":"Sinnreich M, Assal F, Hefft S, Magistris MR, Chizzolini C, Landis T, Burkhard PR. Anti-GAD antibodies and breast cancer in a patient with stiff-person syndrome: a puzzling association. Eur Neurol. 2001;46(1):51\u20132.","journal-title":"Eur Neurol"},{"issue":"8","key":"561_CR16","first-page":"e3125","volume":"10","author":"B Liu","year":"2018","unstructured":"Liu B, Zhou Y, Meng L, Skinner H. A survival case of super-refractory status epilepticus due to\u00a0glutamic acid decarboxylase antibodies-associated limbic encephalitis. Cureus. 2018;10(8):e3125.","journal-title":"Cureus"},{"issue":"1","key":"561_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0022-510X(01)00602-5","volume":"193","author":"H Hagiwara","year":"2001","unstructured":"Hagiwara H, Enomoto-Nakatani S, Sakai K, Ugawa Y, Kusunoki S, Kanazawa I. Stiff-person syndrome associated with invasive thymoma: a case report. J Neurol Sci. 2001;193(1):59\u201362.","journal-title":"J Neurol Sci"},{"issue":"1","key":"561_CR18","doi-asserted-by":"publisher","first-page":"146","DOI":"10.4103\/0972-2327.165462","volume":"19","author":"CM Sharma","year":"2016","unstructured":"Sharma CM, Pandey RK, Kumawat BL, Khandelwal D, Gandhi P. A unique combination of autoimmune limbic encephalitis, type 1 diabetes, and Stiff person syndrome associated with GAD-65 antibody. Ann Indian Acad Neurol. 2016;19(1):146\u20139.","journal-title":"Ann Indian Acad Neurol"},{"issue":"3","key":"561_CR19","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S1474-4422(13)70299-0","volume":"13","author":"M Petit-Pedrol","year":"2014","unstructured":"Petit-Pedrol M, Armangue T, Peng X, Bataller L, Cellucci T, Davis R, McCracken L, Martinez-Hernandez E, Mason WP, Kruer MC, et al. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol. 2014;13(3):276\u201386.","journal-title":"Lancet Neurol"},{"issue":"5","key":"561_CR20","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1001\/archneurol.2011.2985","volume":"69","author":"AM Quek","year":"2012","unstructured":"Quek AM, Britton JW, McKeon A, So E, Lennon VA, Shin C, Klein C, Watson RE, Kotsenas AL, Lagerlund TD, et al. Autoimmune epilepsy: clinical characteristics and response to immunotherapy. Arch Neurol. 2012;69(5):582\u201393.","journal-title":"Arch Neurol"},{"issue":"6","key":"561_CR21","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1002\/mus.23706","volume":"47","author":"G Rakocevic","year":"2013","unstructured":"Rakocevic G, Hussain A. Stiff person syndrome improvement with chemotherapy in a patient with cutaneous T cell lymphoma. Muscle Nerve. 2013;47(6):938\u20139.","journal-title":"Muscle Nerve"},{"issue":"Pt 8","key":"561_CR22","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1093\/brain\/awh526","volume":"128","author":"BM Ances","year":"2005","unstructured":"Ances BM, Vitaliani R, Taylor RA, Liebeskind DS, Voloschin A, Houghton DJ, Galetta SL, Dichter M, Alavi A, Rosenfeld MR, et al. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain. 2005;128(Pt 8):1764\u201377.","journal-title":"Brain"},{"issue":"2","key":"561_CR23","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1136\/adc.2010.183897","volume":"96","author":"E Haberlandt","year":"2011","unstructured":"Haberlandt E, Bast T, Ebner A, Holthausen H, Kluger G, Kravljanac R, Kr\u00f6ll-Seger J, Kurlemann G, Makowski C, Rostasy K, et al. Limbic encephalitis in children and adolescents. Arch Dis Child. 2011;96(2):186\u201391.","journal-title":"Arch Dis Child"},{"issue":"3","key":"561_CR24","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1684\/epd.2014.0666","volume":"16","author":"G Kojima","year":"2014","unstructured":"Kojima G, Inaba M, Bruno MK. PET-positive extralimbic presentation of anti-glutamic acid decarboxylase antibody-associated encephalitis. Epileptic Disord. 2014;16(3):358\u201361.","journal-title":"Epileptic Disord"},{"key":"561_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.yebeh.2016.10.016","volume":"65","author":"N Hansen","year":"2016","unstructured":"Hansen N, Widman G, Witt JA, Wagner J, Becker AJ, Elger CE, Helmstaedter C. Seizure control and cognitive improvement via immunotherapy in late onset epilepsy patients with paraneoplastic versus GAD65 autoantibody-associated limbic encephalitis. Epilepsy Behav. 2016;65:18\u201324.","journal-title":"Epilepsy Behav"},{"issue":"3","key":"561_CR26","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ejpn.2018.01.004","volume":"22","author":"N Ben Achour","year":"2018","unstructured":"Ben Achour N, Ben Younes T, Rebai I, Ben Ahmed M, Kraoua I, Ben Youssef-Turki I. Severe dysautonomia as a main feature of anti-GAD encephalitis: report of a paediatric case and literature review. Eur J Paediatr Neurol. 2018;22(3):548\u201351.","journal-title":"Eur J Paediatr Neurol"},{"issue":"4","key":"561_CR27","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1177\/1941875211413135","volume":"1","author":"PF Finelli","year":"2011","unstructured":"Finelli PF. Autoimmune limbic encephalitis with GAD antibodies. Neurohospitalist. 2011;1(4):178\u201381.","journal-title":"Neurohospitalist"},{"issue":"8","key":"561_CR28","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.seizure.2014.04.009","volume":"23","author":"JB Lilleker","year":"2014","unstructured":"Lilleker JB, Biswas V, Mohanraj R. Glutamic acid decarboxylase (GAD) antibodies in epilepsy: diagnostic yield and therapeutic implications. Seizure. 2014;23(8):598\u2013602.","journal-title":"Seizure"},{"issue":"11","key":"561_CR29","doi-asserted-by":"publisher","first-page":"804","DOI":"10.5692\/clinicalneurol.cn-000740","volume":"55","author":"T Akaishi","year":"2015","unstructured":"Akaishi T, Jin K, Kato K, Itabashi H, Misu T, Tateyama M, Iwasaki M, Aoki M, Nakasato N. Clinical characteristics of four patients with temporal lobe epilepsy associated with elevated anti-GAD antibodies. Rinsho Shinkeigaku. 2015;55(11):804\u20139.","journal-title":"Rinsho Shinkeigaku"},{"issue":"1","key":"561_CR30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.braindev.2009.09.017","volume":"32","author":"N Specchio","year":"2010","unstructured":"Specchio N, Fusco L, Claps D, Vigevano F. Epileptic encephalopathy in children possibly related to immune-mediated pathogenesis. Brain Dev. 2010;32(1):51\u20136.","journal-title":"Brain Dev"},{"issue":"1","key":"561_CR31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1365-2249.2007.03379.x","volume":"149","author":"A Knudsen","year":"2007","unstructured":"Knudsen A, Bredholt G, Storstein A, Oltedal L, Davanger S, Krossnes B, Honnorat J, Vedeler CA. Antibodies to CRMP3-4 associated with limbic encephalitis and thymoma. Clin Exp Immunol. 2007;149(1):16\u201322.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"561_CR32","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1136\/jnnp.67.1.126","volume":"67","author":"IE Silverman","year":"1999","unstructured":"Silverman IE. Paraneoplastic stiff limb syndrome. J Neurol Neurosurg Psychiatry. 1999;67(1):126\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"561_CR33","doi-asserted-by":"publisher","first-page":"449","DOI":"10.4103\/0028-3886.65704","volume":"58","author":"PA Agarwal","year":"2010","unstructured":"Agarwal PA, Ichaporia NR. Glutamic acid decarboxylase antibody-positive paraneoplastic stiff limb syndrome associated with carcinoma of the breast. Neurol India. 2010;58(3):449\u201351.","journal-title":"Neurol India"},{"issue":"3\u20134","key":"561_CR34","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/17402520400001736","volume":"11","author":"Y Ganor","year":"2004","unstructured":"Ganor Y, Goldberg-Stern H, Amrom D, Lerman-Sagie T, Teichberg VI, Pelled D, Futerman AH, Zeev BB, Freilinger M, Verheulpen D, et al. Autoimmune epilepsy: some epilepsy patients harbor autoantibodies to glutamate receptors and dsDNA on both sides of the blood-brain barrier, which may kill neurons and decrease in brain fluids after hemispherotomy. Clin Dev Immunol. 2004;11(3\u20134):241\u201352.","journal-title":"Clin Dev Immunol"},{"issue":"2","key":"561_CR35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/08916930500100825","volume":"38","author":"Y Ganor","year":"2005","unstructured":"Ganor Y, Freilinger M, Dulac O, Levite M. Monozygotic twins discordant for epilepsy differ in the levels of potentially pathogenic autoantibodies and cytokines. Autoimmunity. 2005;38(2):139\u201350.","journal-title":"Autoimmunity"},{"issue":"3","key":"561_CR36","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.braindev.2018.10.006","volume":"41","author":"K Nagai","year":"2019","unstructured":"Nagai K, Maekawa T, Terashima H, Kubota M, Ishiguro A. Severe anti-GAD antibody-associated encephalitis after stem cell transplantation. Brain Dev. 2019;41(3):301\u20134.","journal-title":"Brain Dev"},{"issue":"6","key":"561_CR37","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/epi.12127","volume":"54","author":"T Brenner","year":"2013","unstructured":"Brenner T, Sills GJ, Hart Y, Howell S, Waters P, Brodie MJ, Vincent A, Lang B. Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy. Epilepsia. 2013;54(6):1028\u201335.","journal-title":"Epilepsia"},{"issue":"4","key":"561_CR38","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1001\/jamaneurol.2016.5429","volume":"74","author":"D Dubey","year":"2017","unstructured":"Dubey D, Alqallaf A, Hays R, Freeman M, Chen K, Ding K, Agostini M, Vernino S. Neurological autoantibody prevalence in epilepsy of unknown etiology. JAMA Neurol. 2017;74(4):397\u2013402.","journal-title":"JAMA Neurol"},{"issue":"6","key":"561_CR39","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/j.1468-1331.2011.03609.x","volume":"19","author":"M Falip","year":"2012","unstructured":"Falip M, Carre\u00f1o M, Mir\u00f3 J, Saiz A, Villanueva V, Qu\u00edlez A, Molins A, Barcel\u00f3 I, Sierra A, Graus F. Prevalence and immunological spectrum of temporal lobe epilepsy with glutamic acid decarboxylase antibodies. Eur J Neurol. 2012;19(6):827\u201333.","journal-title":"Eur J Neurol"},{"issue":"4","key":"561_CR40","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/ana.21917","volume":"67","author":"MP Malter","year":"2010","unstructured":"Malter MP, Helmstaedter C, Urbach H, Vincent A, Bien CG. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol. 2010;67(4):470\u20138.","journal-title":"Ann Neurol"},{"key":"561_CR41","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.yebeh.2017.10.033","volume":"79","author":"N Hansen","year":"2018","unstructured":"Hansen N, Ernst L, R\u00fcber T, Widman G, Becker AJ, Elger CE, Helmstaedter C. Pre- and long-term postoperative courses of hippocampus-associated memory impairment in epilepsy patients with antibody-associated limbic encephalitis and selective amygdalohippocampectomy. Epilepsy Behav. 2018;79:93\u20139.","journal-title":"Epilepsy Behav"},{"issue":"3","key":"561_CR42","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1159\/000369058","volume":"6","author":"M Bonello","year":"2014","unstructured":"Bonello M, Larner AJ, Marson AG. Profound amnesia after temporal lobectomy: an autoimmune process resembling patient hm. Case Rep Neurol. 2014;6(3):251\u20135.","journal-title":"Case Rep Neurol"},{"issue":"9","key":"561_CR43","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1111\/ene.12186","volume":"20","author":"C Frisch","year":"2013","unstructured":"Frisch C, Malter MP, Elger CE, Helmstaedter C. Neuropsychological course of voltage-gated potassium channel and glutamic acid decarboxylase antibody related limbic encephalitis. Eur J Neurol. 2013;20(9):1297\u2013304.","journal-title":"Eur J Neurol"},{"issue":"26","key":"561_CR44","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1056\/NEJMoa01167","volume":"345","author":"MC Dalakas","year":"2001","unstructured":"Dalakas MC, Fujii M, Li M, Lutfi B, Kyhos J, McElroy B. High-dose intravenous immune globulin for stiff-person syndrome. N Engl J Med. 2001;345(26):1870\u20136.","journal-title":"N Engl J Med"},{"issue":"11","key":"561_CR45","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1586\/1744666X.2013.845527","volume":"9","author":"H Alexopoulos","year":"2013","unstructured":"Alexopoulos H, Dalakas MC. Immunology of stiff person syndrome and other GAD-associated neurological disorders. Expert Rev Clin Immunol. 2013;9(11):1043\u201353.","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"561_CR46","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/jnnp.2004.036558","volume":"76","author":"S Thomas","year":"2005","unstructured":"Thomas S, Critchley P, Lawden M, Farooq S, Thomas A, Proudlock FA, Constantinescu CS, Gottlob I. Stiff person syndrome with eye movement abnormality, myasthenia gravis, and thymoma. J Neurol Neurosurg Psychiatry. 2005;76(1):141\u20132.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2B","key":"561_CR47","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1590\/S0004-282X2004000300033","volume":"62","author":"M Spitz","year":"2004","unstructured":"Spitz M, Ferraz HB, Barsottini OG, Gabbai AA. Progressive encephalomyelitis with rigidity: a paraneoplastic presentation of oat cell carcinoma of the lung. Case report. Arq Neuropsiquiatr. 2004;62(2B):547\u20139.","journal-title":"Case report. Arq Neuropsiquiatr"},{"key":"561_CR48","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3389\/fneur.2018.00579","volume":"9","author":"KM M\u00e4kel\u00e4","year":"2018","unstructured":"M\u00e4kel\u00e4 KM, Hietaharju A, Brander A, Peltola J. Clinical management of epilepsy with glutamic acid decarboxylase antibody positivity: the interplay between immunotherapy and anti-epileptic drugs. Front Neurol. 2018;9:579.","journal-title":"Front Neurol"},{"issue":"12","key":"561_CR49","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1212\/01.wnl.0000325917.48466.55","volume":"71","author":"F Graus","year":"2008","unstructured":"Graus F, Saiz A, Lai M, Bruna J, L\u00f3pez F, Sabater L, Blanco Y, Rey MJ, Ribalta T, Dalmau J. Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations. Neurology. 2008;71(12):930\u20136.","journal-title":"Neurology"},{"issue":"7","key":"561_CR50","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1469-8749.2008.03217.x","volume":"51","author":"CI Akman","year":"2009","unstructured":"Akman CI, Patterson MC, Rubinstein A, Herzog R. Limbic encephalitis associated with anti-GAD antibody and common variable immune deficiency. Dev Med Child Neurol. 2009;51(7):563\u20137.","journal-title":"Dev Med Child Neurol"},{"issue":"8","key":"561_CR51","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1515\/jpem-2016-0016","volume":"29","author":"E Grilo","year":"2016","unstructured":"Grilo E, Pinto J, Caetano JS, Pereira H, Cardoso P, Cardoso R, Dinis I, Pereira C, Fineza I, Mirante A. Type 1 diabetes and GAD65 limbic encephalitis: a case report of a 10-year-old girl. J Pediatr Endocrinol Metab. 2016;29(8):985\u201390.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"4","key":"561_CR52","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1684\/epd.2013.0607","volume":"15","author":"ME Garc\u00eda Garc\u00eda","year":"2013","unstructured":"Garc\u00eda Garc\u00eda ME, Castrillo SM, Morales IG, Di Capua Sacoto D, Dolado AM. Acute amnesia and seizures in a young female. Epileptic Disord. 2013;15(4):455\u201360.","journal-title":"Epileptic Disord"},{"key":"561_CR53","doi-asserted-by":"publisher","first-page":"2013202314","DOI":"10.1136\/bcr-2013-202314","volume":"2014","author":"Z Georgieva","year":"2014","unstructured":"Georgieva Z, Parton M. Cerebellar ataxia and epilepsy with anti-GAD antibodies: treatment with IVIG and plasmapheresis. BMJ Case Rep. 2014;2014:2013202314.","journal-title":"BMJ Case Rep"},{"issue":"1\u20132","key":"561_CR54","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jns.2014.05.032","volume":"343","author":"I Markakis","year":"2014","unstructured":"Markakis I, Alexopoulos H, Poulopoulou C, Akrivou S, Papathanasiou A, Katsiva V, Lyrakos G, Gekas G, Dalakas MC. Immunotherapy-responsive limbic encephalitis with antibodies to glutamic acid decarboxylase. J Neurol Sci. 2014;343(1\u20132):192\u20134.","journal-title":"J Neurol Sci"}],"container-title":["BMC Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-020-00561-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12868-020-00561-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-020-00561-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T23:26:57Z","timestamp":1617060417000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurosci.biomedcentral.com\/articles\/10.1186\/s12868-020-00561-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,30]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["561"],"URL":"https:\/\/doi.org\/10.1186\/s12868-020-00561-9","relation":{},"ISSN":["1471-2202"],"issn-type":[{"value":"1471-2202","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,30]]},"assertion":[{"value":"4 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Medical Ethics Committee of Beijing Tiantan Hospital, Capital Medical University, and was carried out in accordance with the Declaration of Helsinki. We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines. All participants gave written informed consent to participate.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants provided written consent for publication for the publication of clinical details.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"On behalf of all authors, the corresponding author confirms no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}